Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Brain chemistry clues sought in rare gaucher disease study

NCT ID NCT05586243

First seen Jan 10, 2026 · Last updated May 22, 2026 · Updated 17 times

Summary

This study aims to identify brain chemical markers in adults with Type 3 Gaucher disease using a special MRI technique called magnetic resonance spectroscopy. Researchers will measure up to 18 brain metabolites to see if they can track disease activity and treatment response. Only 5 participants will be enrolled, all of whom must be 18 or older and medically stable. The study does not test any new treatment, but seeks to improve understanding of how the disease affects the brain.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GAUCHER DISEASE TYPE 3 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Minnesota

    RECRUITING

    Minneapolis, Minnesota, 55455, United States

    Contact

    Contact

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.